| Patents for C07K 16 - Immunoglobulins, e.g. monoclonal or polyclonal antibodies (149,320) |
|---|
| 07/23/2014 | EP2756094A1 Anti-b7-h4 antibodies and their uses |
| 07/23/2014 | EP2756004A1 METHODS FOR REDUCING LIPOPROTEIN(a) LEVELS BY ADMINISTERING AN INHIBITOR OF PROPROTEIN CONVERTASE SUBTILISIN KEXIN-9 (PCSK9) |
| 07/23/2014 | EP2756003A1 Antibodies to pcsk9 and uses thereof |
| 07/23/2014 | EP2756002A2 Compositions and methods related to dna damage repair |
| 07/23/2014 | EP2756001A2 Anti-cd134 (ox40) antibodies and uses thereof |
| 07/23/2014 | EP2756000A1 B7-h6 therapeutically active monoclonal antibody against b7-h6 polypeptide |
| 07/23/2014 | EP2755999A2 Anti-aplhabetatcr antibody |
| 07/23/2014 | EP2755998A1 Antibodies against e7 protein of human papilloma virus (hpv) |
| 07/23/2014 | EP2755997A1 T cell receptors recognizing hla-a1- or hla-cw7-restricted mage |
| 07/23/2014 | EP2755683A2 Methods for making saccharide-protein glycoconjugates |
| 07/23/2014 | CN1833030B 用于表达、传递及纯化目标多肽的重组载体分子 Expression vectors used in recombinant molecules, and purification of the target polypeptide is passed |
| 07/23/2014 | CN103946242A 抗cd22嵌合抗原受体 Anti-cd22 chimeric antigen receptor |
| 07/23/2014 | CN103946241A 赖氨酰氧化酶样2分析法及其使用方法 Lysyl oxidase-like 2 assay and methods of use |
| 07/23/2014 | CN103946240A 对人ox40具有特异性的抗体分子 Ox40 human antibody molecule having specificity for |
| 07/23/2014 | CN103946239A 用于治疗b细胞慢性淋巴细胞性白血病和其他恶性血液病的cd44单克隆抗体 Cd44 for the treatment of b-cell chronic lymphocytic leukemia and other hematologic malignancies monoclonal antibody |
| 07/23/2014 | CN103946238A 抗ox40抗体及使用其的方法 Anti ox40 methods of using the antibodies and |
| 07/23/2014 | CN103946237A 白蛋白结合抗体及其结合片段 Albumin binding antibodies and binding fragments |
| 07/23/2014 | CN103946236A 表达cd40l的哺乳动物细胞及其用途 Expression of mammalian cells and their use cd40l |
| 07/23/2014 | CN103945689A 免疫球蛋白基因多样性的操纵及多抗体治疗剂 Manipulation of immunoglobulin gene diversity and multi-antibody therapeutics |
| 07/23/2014 | CN103941017A C反应蛋白检测试剂盒 C-reactive protein assay kit |
| 07/23/2014 | CN103941016A 半胱氨酸蛋白酶抑制剂sn与癌胚抗原的联合应用 Cysteine protease inhibitor in combination with carcinoembryonic antigen sn |
| 07/23/2014 | CN103941011A 检测单核细胞增生性李斯特菌的方法及其单抗 Detection of Listeria monocytogenes bacteria method and monoclonal antibodies |
| 07/23/2014 | CN103937817A 鸡新城疫病毒yt毒株、其全基因组序列及其应用 Yt strain of Newcastle disease virus, its genome sequence and its applications |
| 07/23/2014 | CN103937751A 一种基于ndv血凝素蛋白单克隆抗体的胶体金免疫层析检测试纸条 GICA test strip a ndv hemagglutinin protein monoclonal antibody-based |
| 07/23/2014 | CN103937750A 抗大豆球蛋白的单克隆抗体及其应用 Monoclonal antibodies anti-glycinin and its application |
| 07/23/2014 | CN103936860A 双特异性抗-vegf/抗-ang-2抗体 Bispecific anti -vegf / anti -ang-2 antibody |
| 07/23/2014 | CN103936859A 人源化l243抗体 Humanized antibody l243 |
| 07/23/2014 | CN103936858A 抗cd20抗原的抗体l5h6及其应用 Anti-cd20 antigens l5h6 Its Applications |
| 07/23/2014 | CN103936857A 抗cd20抗原的抗体l5h5及其应用 Anti-cd20 antigens l5h5 Its Applications |
| 07/23/2014 | CN103936856A 抗cd20抗原的抗体l4h7及其应用 Anti-cd20 antigens l4h7 Its Applications |
| 07/23/2014 | CN103936855A 抗cd20抗原的抗体l4h5及其应用 Anti-cd20 antigens l4h5 Its Applications |
| 07/23/2014 | CN103936854A 抗il-17a单克隆抗体及其制备与应用 Anti-il-17a and its preparation and application of monoclonal antibodies |
| 07/23/2014 | CN103936853A 一种检测tim-3试剂盒及其使用方法 A tim-3 detection kit and method of use |
| 07/23/2014 | CN103936852A 特异性针对甲型h3n2流感病毒的纳米抗体及其在诊断中的应用 Specific application for influenza h3n2 influenza virus Nanobodies its diagnosis |
| 07/23/2014 | CN103936851A 一种分离免疫球蛋白抗体的方法 A method for separating immunoglobulin antibodies |
| 07/23/2014 | CN103936850A 用于鸡卵黄免疫球蛋白提取的复合型去脂液及应用 Degreasing solution for complex and application of chicken egg yolk immunoglobulins extracted |
| 07/23/2014 | CN103193883B 一种特异性莱克多巴胺人工抗原的合成方法 A method of synthesizing artificial antigen-specific ractopamine |
| 07/23/2014 | CN102066420B 1d05 pcsk9拮抗剂 1d05 pcsk9 antagonist |
| 07/23/2014 | CN101484470B 具有增强的抗体依赖性细胞毒性活性的抗体及其生产方法和用途 With enhanced antibody-dependent cytotoxic activity of an antibody and its production method and use thereof |
| 07/23/2014 | CN101460522B 糖基化抗体 Glycosylated ANTIBODY |
| 07/23/2014 | CN101238149B 新抗igf-ir抗体及其用途 The new anti-igf-ir antibodies and their use |
| 07/23/2014 | CN101090729B 前列腺干细胞抗原(psca)变体及其序列 Prostate stem cell antigen (psca) and sequence variants |
| 07/23/2014 | CN101018808B 调节肿瘤坏死因子α的组合物和方法 Regulation of tumor necrosis factor-α compositions and methods |
| 07/22/2014 | US8788212 Compositions and methods for biological remodeling with frozen particle compositions |
| 07/22/2014 | US8785618 Method of delivering RNA interference and uses thereof |
| 07/22/2014 | US8785609 Cloning and expression of HTLV-III DNA |
| 07/22/2014 | US8785605 Humanized IL-25 antibodies |
| 07/22/2014 | US8785604 Anti-CD28 humanized antibodies |
| 07/22/2014 | US8785603 Antibodies to 25-hydroxyvitamin D2 and D3 and uses thereof |
| 07/22/2014 | US8785602 EMP2 antibodies and methods of use thereof for causing regression of a solid tumor or symptoms thereof |
| 07/22/2014 | US8785601 T cell receptors and related materials and methods of use |
| 07/22/2014 | US8785599 FcγRIIB—specific antibodies and methods of use thereof |
| 07/22/2014 | US8785392 Method for inhibiting cancer metastasis by administration of the extracellular domain DLK1 or a DLK1-FC fusion protein |
| 07/22/2014 | US8785391 Compound and method for treatment of alzheimer's disease and familial dementia |
| 07/22/2014 | US8785202 Colloidal metal compositions and methods |
| 07/22/2014 | US8785151 Biosynthetically generated pyrroline-carboxy-lysine and site specific protein modifications via chemical derivatization of pyrroline-carboxy-lysine and pyrrolysine residues |
| 07/22/2014 | US8784836 Microorganisms for therapy |
| 07/22/2014 | US8784831 P. gingivalis antigenic composition |
| 07/22/2014 | US8784830 Antigen peptide and use thereof |
| 07/22/2014 | US8784829 Lawsonia intracellularis vaccines |
| 07/22/2014 | US8784824 Compositions and methods for treatment of angiogenesis in pathological lesions |
| 07/22/2014 | US8784823 Binding proteins, including antibodies, antibody derivatives and antibody fragments, that specifically bind CD154 and uses thereof |
| 07/22/2014 | US8784821 Human-anti-human cd3 binding molecules |
| 07/22/2014 | US8784818 Anti-VEGFR-3 antibody compositions |
| 07/22/2014 | US8784817 Method for killing IL-1 alpha expressing cells |
| 07/22/2014 | US8784816 Antibodies which bind factor VIII |
| 07/22/2014 | US8784815 Human CTLA-4 antibodies and their uses |
| 07/22/2014 | US8784814 Method for inhibiting binding to B-cell receptor |
| 07/22/2014 | US8784811 Method of treating cancer using antibodies to a non-ligand binding region of NOTCH1 |
| 07/22/2014 | US8784809 Vascular endothelial growth factor 2 |
| 07/22/2014 | US8784808 FcγRIIB specific antibodies and methods of use thereof |
| 07/22/2014 | US8784777 Flexibly labeling peptides |
| 07/22/2014 | US8784385 Frozen piercing implements and methods for piercing a substrate |
| 07/22/2014 | CA2584489C Kaspp (lrrke) gene, its production and use for the detection and treatment of neurodegenerative disorders |
| 07/22/2014 | CA2573144C Methods for treating conditions associated with masp-2 dependent complement activation |
| 07/22/2014 | CA2570324C Rage fusion proteins and methods of use |
| 07/22/2014 | CA2546157C Improved expression systems with sec-system secretion |
| 07/22/2014 | CA2442074C Methods of detecting early renal disease in animals |
| 07/22/2014 | CA2412845C Enhancement of antibody-cytokine fusion protein mediated immune responses by combined treatment with immunocytokine uptake enhancing agents |
| 07/22/2014 | CA2388562C Mammalian cytokines; related reagents and methods |
| 07/22/2014 | CA2383774C Fibroblast growth factor-like polypeptides |
| 07/17/2014 | WO2014110601A1 Novel heterodimeric proteins |
| 07/17/2014 | WO2014110503A1 Methods and compositions for treating cancer |
| 07/17/2014 | WO2014110438A1 Compounds and methods related to the c5d domain of complement component c5 |
| 07/17/2014 | WO2014110368A1 Bovine fusion antibodies |
| 07/17/2014 | WO2014109999A1 ANTI-PDGFR-beta ANTIBODIES AND USES THEREOF |
| 07/17/2014 | WO2014109656A1 Modified gene of human activation-induced cytidine deaminase (aid), a method of modification of human aid gene, a composition showing aid activity, a method of preparation of such composition in a bacterial system and use of the composition in the analyses of dna/rna amination/deamination and/or methylation/demethylation |
| 07/17/2014 | WO2014108854A1 Monospecific anti-hgf and anti-ang2 antibodies and bispecific anti-hgf/anti-ang2 antibodies |
| 07/17/2014 | WO2014108829A1 New antibody fragments, compositions and uses thereof |
| 07/17/2014 | WO2014108707A1 Identification of patients for breast cancer theraphy using t128 family members as markers |
| 07/17/2014 | WO2014108484A2 Combination therapy of anti-her3 antibodies |
| 07/17/2014 | WO2014108483A1 Inert format |
| 07/17/2014 | WO2014108456A1 Use of antibodies against icam-1 in combination with an anti cancer drug in the treatment of patients |
| 07/17/2014 | WO2014108198A1 Human igg1 fc region variants and uses thereof |
| 07/17/2014 | WO2014058924A9 Antibodies recognizing alpha-synuclein |
| 07/17/2014 | WO2012156532A8 Anti-human-her3 antibodies and uses thereof |
| 07/17/2014 | US20140201854 Animal models and therapeutic molecules |
| 07/17/2014 | US20140200332 Low dose methods for treating disorders in which tnf-alpha activity is detrimental |
| 07/17/2014 | US20140200331 Engineered Immunoglobulin Heavy Chain-Light Chain Pairs And Uses Thereof |
| 07/17/2014 | US20140200165 Novel fab fragment libraries and methods for their use |